Full text loading...
- ISSN: 2666-7967
- E-ISSN: 2666-7975
-
Lactate is Associated with Long-term Mortality in Hospitalized Patients with COVID-19: A Retrospective Cohort Study
- Source: Coronaviruses, Volume 6, Issue 3, Sep 2025, E150424228893
-
- 22 Nov 2023
- 20 Feb 2024
- 15 Apr 2024
Abstract
Introduction
A recent pandemic caused by Coronavirus 2019 (COVID-19) caused mild and severe systemic organ involvement that led to the death of enormous numbers of people. The prevalence of the disease has declined in recent years, but concerns about emerging mutations remain. In this study, the relationship between lactate levels and mortality at different times was investigated.
Methods
In the present retrospective study, 228 hospitalized patients with COVID-19 were included according to the inclusion and exclusion criteria. A modified National Early Warning Score 2 (NEWS2) was used to determine the severity of the patients' conditions. Follow-up of patients, if discharged alive, has been done from hospitalization until March, 2022. Data were analyzed using SPSS version 22, and p < 0.05 was considered significant.
Results
Lactate levels (2.88 ± 2.37 mmol/L in the deceased group vs. 1.68 ± 1.33 mmol/L in the surviving group) show a significant association with in-hospital mortality (p < 0.001). Furthermore, higher lactate levels during hospitalization (p < 0.001, HR = 2.960, 95%CI =4.255-2.58) and follow-up (p < 0.001, HR = 2.085, 95% CI =1.441 to 3.015) increased the mortality risk ratio by more than two-fold.
Conclusion
This study reported that initial lactate levels at admission predict COVID-19 patients' mortality at hospitalization and follow-up. However, further research is needed in this area.
©
2025 Bentham Science Publishers